Physician profile
Stuart Bergman
NPI 1992859805
$521.93
in general payments reported to CMS, 2019-2025
13 companies · $25.97 in 2025
The $25.97 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.20 · 2021: $63.59 · 2022: $224 · 2023: $191 · 2025: $25.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $91.53 | 2022 | |
| Janssen Biotech, INC. | $79.56 | 2021-2025 | Erleada |
| Tolmar Pharmaceuticals, INC. | $61.99 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $58.04 | 2022-2023 | Lynparza, Keytruda, Welireg |
| Sumitomo Pharma America, INC. | $54.19 | 2023 | Gemtesa |
| Boston Scientific Corporation | $30.12 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $29.09 | 2022-2023 | Seglentis |
| Kyowa Kirin, INC. | $22.69 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.37 | 2023 | |
| Endo Pharmaceuticals INC. | $21.04 | 2023 | Xiaflex |
| Pfizer INC. | $17.45 | 2023 | |
| 180 Medical, INC. | $17.20 | 2019 | |
| Myovant Sciences INC. | $16.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Bergman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.